SENSITIVITY OF 2018 KAZAKHSTAN INFLUENZA TYPE B VIRUSES TO ANTIVIRAL DRUGS

SENSITIVITY OF 2018 KAZAKHSTAN INFLUENZA TYPE B VIRUSES TO ANTIVIRAL DRUGS

.

Bibliographic Details
Main Authors:	G. V. Lukmanova, N. G. Klivleyeva, A. M. Baimukhametova, N. S. Ongarbayeva, M. K. Kalkozhayeva, S. B. Baiseiit, T. I. Glebova
Format:	Article
Language:	Russian
Published:	Sankt-Peterburg : NIIÈM imeni Pastera 2018-12-01
Series:	Infekciâ i Immunitet
Online Access:	https://www.iimmun.ru/iimm/article/view/919

Similar Items

2018 – 2019 ANTIVIRAL DRUG SENSITIVITY OF THE INFLUENZA VIRUS STRAINS ISOLATED FROM VARIOUS REGIONS OF KAZAKHSTAN
by: T. Glebova, et al.
Published: (2019-06-01)

CIRCULATION OF INFLUENZA VIRUSES AMONG HUMANS AND SWINE IN THE REGIONS OF NORTHERN AND WESTERN KAZAKHSTAN IN 2017–2018
by: S. B. Baiseiit, et al.
Published: (2018-12-01)

STUDY ON HERD IMMUNITY AGAINST INFLUENZA VIRUS AMONG THE POPULATION OF ALMATY REGION IN 2017–2018
by: A. M. Baimukhametova, et al.
Published: (2018-12-01)

Detection of influenza virus and pathogens of acute respiratory viral infections in population of Kazakhstan during 2018-2019 epidemic season
by: N. G. Klivleyeva, et al.
Published: (2021-02-01)

Antiviral activities of extremophilic actinomycetes extracts from Kazakhstan’s unique ecosystems against influenza viruses and paramyxoviruses
by: Vladimir Berezin, et al.
Published: (2019-12-01)

Can antiviral drugs contain pandemic influenza transmission?
by: Niels G Becker, et al.
Published: (2011-01-01)

Development and Effects of Influenza Antiviral Drugs
by: Hang Yin, et al.
Published: (2021-02-01)

Influenza viruses – antiviral therapy and resistance
by: Duwe, Susanne
Published: (2017-04-01)

Antiviral Response in Pandemic Influenza Viruses
by: Adolfo García-Sastre
Published: (2006-01-01)

Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011
by: V A Potdar, et al.
Published: (2014-01-01)

Optimizing Distribution of Pandemic Influenza Antiviral Drugs
by: Bismark Singh, et al.
Published: (2015-02-01)

Antiviral strategies for emerging influenza viruses in remote communities.
by: Marek Laskowski, et al.
Published: (2014-01-01)

Rare Influenza A (H3N2) Variants with Reduced Sensitivity to Antiviral Drugs
by: Clyde Dapat, et al.
Published: (2010-03-01)

MOLECULAR EPIDEMIOLOGY OF TUBERCULOSIS IN KAZAKHSTAN, 2006–2018
by: Y. Skiba, et al.
Published: (2018-12-01)

Mouse-adapted influenza B virus for in vitro and in vivo assessment of therapeutic and preventive efficacy of antiviral drugs
by: E. A. Prokopyeva, et al.
Published: (2019-12-01)

Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation
by: J Burch, et al.
Published: (2009-11-01)

DOMESTIC SPECTRUM OF ANTIVIRAL DRUG — UMIFENOVIR AS ETIOTROPIC THERAPY OF INFLUENZA
by: L. V. Osidak, et al.
Published: (2016-09-01)

The Use of Antiviral Drugs for Influenza: Recommended Guidelines for Practitioners
by: Upton D Allen, et al.
Published: (2006-01-01)

Perspective of Use of Antiviral Peptides against Influenza Virus
by: Sylvie Skalickova, et al.
Published: (2015-10-01)

Iminosugars as antivirals against human influenza A viruses
by: Hussain, S.
Published: (2013)

Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus.
by: Justin D Hoopes, et al.
Published: (2011-01-01)

Ocular effects of hepatitis c virus antiviral drugs
by: Thanaa H Mohammed, et al.
Published: (2018-01-01)

Avian influenza viruses in wild birds in Georgia, 2018–2019
by: A. Machablishvili, et al.
Published: (2020-12-01)

Antiviral resistance during pandemic influenza: implications for stockpiling and drug use
by: Bowman Christopher S, et al.
Published: (2009-01-01)

Sensitivity of a ribavirin resistant mutant of hepatitis C virus to other antiviral drugs.
by: Kathleen B Mihalik, et al.
Published: (2013-01-01)

Evolution of influenza viruses based on sensitivity to temperature of replication
by: N. V. Larionova, et al.
Published: (2019-12-01)

Potential Impact of Antiviral Drug Use during Influenza Pandemic
by: Raymond Gani, et al.
Published: (2005-09-01)

The Use of Antiviral Drugs for Influenza: Guidance for Practitioners 2012/2013
by: Fred Y Aoki, et al.
Published: (2012-01-01)

The Use of Antiviral Drugs for Influenza: A Foundation Document for Practitioners
by: Fred Y Aoki, et al.
Published: (2013-01-01)

INFLUENZA VIRUS SURVEILLANCE BY THE INSTITUTO ADOLFO LUTZ, INFLUENZA SEASON 2014: ANTIVIRAL RESISTANCE
by: Katia Corrêa de Oliveira Santos, et al.
Published: (2015-02-01)

Antiviral Activity of Isoquinolone Derivatives against Influenza Viruses and Their Cytotoxicity
by: Yejin Jang, et al.
Published: (2021-07-01)

Influenza viruses that require 10 genomic segments as antiviral therapeutics.
by: Alfred T Harding, et al.
Published: (2019-11-01)

Identification and Characterization of Compounds with Antiviral Activity against Influenza Viruses
by: Vazquez, Ana Carolina
Published: (2008)

Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets.
by: Erhard van der Vries, et al.
Published: (2013-01-01)

Estudio de sensibilidad antiviral de Virus Herpes simplex en pacientes trasplantados Antiviral sensitivity of Herpes simplex virus in immunocompromised patients
by: H. Illán, et al.
Published: (2004-06-01)

Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target
by: Emilio Yángüez, et al.
Published: (2018-09-01)

Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017
by: Toledo-Rueda W, et al.
Published: (2018-10-01)

The Antiviral Role of Galectins toward Influenza A Virus Infection—An Alternative Strategy for Influenza Therapy
by: Chih-Yen Lin, et al.
Published: (2021-05-01)

Antiviral prophylaxis during pandemic influenza may increase drug resistance
by: Koch Daniel, et al.
Published: (2009-01-01)

Influenza A virus infection in zebrafish recapitulates mammalian infection and sensitivity to anti-influenza drug treatment
by: Kristin A. Gabor, et al.
Published: (2014-11-01)